Clinical Outcomes of CoVid-19 in Patients Taking Tumor Necrosis Factor Inhibitors and/or Methotrexate: A Multi-Center Research Network Study
This study supports the ongoing use of tumor necrosis factor inhibitors and/or methotrexate therapy.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Ahmed Yousaf, Swapna Gayam, Steve Feldman, Zachary Zinn, Michael Kolodney Source Type: research